Craft

Oxagen

Total Funding

$130.6 M

Revenue

£24.2 K

FY, 2015

Oxagen Summary

Company Summary

Overview
Oxagen is a biopharmaceutical company that provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. 
Type
Private
Status
Active
Founded
1997
HQ
Abingdon, GB | view all locations
Website
http://www.oxagen.co.uk/
Cybersecurity rating
Sectors

Key People

  • Timothy Edwards, Non-Executive Chairman

    • Regina Hodits, Non-Executive Director

      LocationsView all

      1 location detected

      • Abingdon HQ

        United Kingdom

        99 Park Dr

      Oxagen Financials

      Summary Financials

      Revenue (FY, 2015)
      £24.2K
      Net income (FY, 2015)
      (£251.1K)
      Cash (FY, 2018)
      £62.9K
      EBIT (FY, 2015)
      (£291.7K)

      Footer menu